Fundraising Fox

VIB

Foundation

Ghent · Seed–Late Stage · 9 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

VIB is a Flemish life sciences research institute focused on conducting groundbreaking biomolecular research for scientific and societal benefit. It allocates most of its budget to research, with a significant share dedicated to technology transfer aimed at converting research into viable business ventures for consumer and patient benefit. Its research spans humans, plants, and microorganisms, studying normal and pathological cellular and organismal processes. Researchers are embedded within departments across four Flemish universities to foster collaboration. As a member of EU-LIFE, VIB emphasizes excellence in life sciences, dissemination of scientific knowledge to the public, and contribution to economic development.

Invests inAgTechBiotechFoodTechBelgiumBrazilGlobal

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Ghent, BE
Leads rounds
Follows
Instruments
Equity
Founded
1995
Tracked investments
3

Team · 9 people

from the firm's website
Christine Durinx

Part of VIB's leadership team guiding the institute's scientific and strategic direction.

Ajit Shetty· Chairman of the Board of Directors

Chairs VIB's board of directors.

Dr. Els Hermans· Program Manager Translational Research
Dr. Laurien Van Dyck· Portfolio Manager
Dr. Valeria Imperato· Project Portfolio Officer
Els Hermans· Program Manager Translational Research
Laurien Van Dyck· Portfolio Manager
Valeria Imperato· Project Portfolio Officer

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Healthtech ×2AgTech ×1FoodTech ×1

HQs:Belgium×3

Investments · 3 tracked

founders shown can be your intro path
Montis Biosciencesmontisbio.com✓ verified

Montis Biosciences develops anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome and a second CD93 program in lung squamous cell carcinoma.

BiotechHealthtechLeuven, BE

Federico Grossi(Clinical Advisor & Acting CMO)

Protealisprotealis.comin✓ verified

Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.

AgTechBiotechFoodTechGent, BE

Benjamin Laga(Co-founder & CEO)Jonas Aper(Co-founder & Director of Breeding)

visit www.montisbiosciences.commontisbiosciences.com✓ verified

Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome.

BiotechHealthtechLeuven, BE

Federico Grossi(Clinical Advisor & Acting CMO)

Frequently asked questions

What stage does VIB invest at?
VIB invests at the Seed, Series A, Late Stage stages.
What sectors does VIB focus on?
VIB focuses on AgTech, Biotech, FoodTech.
Where is VIB located?
VIB is headquartered in Ghent, BE.
Does VIB lead rounds?
VIB typically participates in rounds rather than leading them.

Media · Podcasts & interviews

from their channel

NEW | Episode 14: Lia Martina – From pipettes to policy

VIB

NEW | Episode 12: Ayşe Candayan – Grants, genes, and grit

VIB

NEW | Episode 13: Thomas Jacobs – Transplanting, adapting, and flourishing in a new environment

VIB

NEW | Episode 11: Laurent Galibert – A lifelong mission in drug discovery

VIB

NEW | Episode 15: Inge Van Molle – What it takes to be a jack of all trades

VIB

BioImaging Core Cribs

VIB

Images

VIB photoVIB photoVIB photoVIB photoVIB photoVIB photo

Similar investors

Featured in lists